DERM

Journey Medical CORP

-$28.6M

Net Activity

Institutions Holding

71

Popularity Rank

#5203

Avg Weight

0.03%

Total Value

$55.3M

Ownership Trend

71 institutions currently hold DERM, with 40 net buyers and 34 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

34

Net Buying Institutions

40

Key Holders

View all 71 holding institutions

Quarterly Activity

Recent Activity

+$26.4M

Total Buy Value

$45.5M

Total Sell Value

New buy8
Trim19
Add32
Sold out15

40

Net Buyers

34

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

1

Active 5%+ Holders

Data as of 2026-07-15
Reporting PersonTypeFiling Date% of Class
Wasatch Advisors LP13G/A2026-07-1513.3%

View all Schedule 13D/13G filings

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding JOURNEY MEDICAL CORP (DERM)?
Major stakeholders currently include Wasatch Advisors LP ($10.0M), Tang Capital Management LLC ($7.6M), Vanguard Capital Management LLC ($5.1M). Based on the latest 13F filings, there are a total of 71 tracked investment funds and institutions maintaining positions in DERM.
What is the overall institutional sentiment toward DERM recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $28.6M, driven by 40 managers accumulating shares while 34 reduced their exposure.
Which institutions have been selling or reducing their DERM positions?
In the latest period, 19 funds trimmed their holdings, and 15 managers completely exited their positions. The aggregate reported sell value was $45.5M.
Are there any notable investors adding DERM to their portfolios?
Yes, buying activity remains notable. 8 institutions opened new positions in {ticker}, and 32 existing holders added to their shares. The total reported buy value for the quarter amounted to $26.4M.

Related Stocks